Evidence mapPaperPMID 24239921Full record

GuidelineJournal of the American College of Cardiology2014

2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

David C Goff, Donald M Lloyd-Jones, Glen Bennett, Sean Coady, Ralph B D'Agostino, Raymond Gibbons, Philip Greenland, Daniel T Lackland, Daniel Levy, Christopher J O'Donnell and 7 more

Erratum issued 4 registry-linked trialsAbstract readPractice Guideline
In one paragraph

Guideline in Journal of the American College of Cardiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 4 registered trials, which are not on this map. Cited by 1,394 papers.

0numbers the graph read from it
0cells of the map it votes in
1,394citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02344290 phase3completedstarted 2015, after this paper: background citation

Randomized Trial to Prevent Vascular Events in HIV - REPRIEVE

Ran2015Enrolled7,769Registered outcomes37Posted comparisons40ConditionsCardiovascular Diseases, HIVArmsPitavastatin, Placebo
Open the trial in the graph
NCT03696940 phase3unknown statusstarted 2018, after this paper: background citation

Estudio clínico Fase III Para Evaluar la Eficacia terapéutica en Pacientes Mexicanos Con Dislipidemia Mediante el Uso vía Oral de L-Carnitina + Atorvastatina Comparado Con Atorvastatina

Ran2018Enrolled120Registered outcomes6Posted comparisons0ConditionsCardiovascular Risk Factor, DyslipidemiasArmsAtorvastatin 10mg, L-Carnitine 500Mg Oral Tablet + Atorvastatin 10 mg
Open the trial in the graph
NCT05171283 unknown statusnot on this mapstarted 2021, after this paper: background citation

Oat Fiber and Cardiovascular Risk Reduction: A Systematic Review and Meta-analysis of Randomized Controlled Trials

TypeobservationalSponsorUniversity of TorontoRan2021 to 2024Enrolled1ConditionsCardiovascular Diseases, Coronary Heart DiseaseArmsOats or Oat Fibre
NCT07719621 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Implication of Albuminuria Reduction and Other Cardiorenal Effects on The Risk of Heart Failure in Patients With CKD and T2D

TypeobservationalSponsorAeterna Medical Solutions SLRan2026 to 2026Enrolled50,000ConditionsCKD - Chronic Kidney Disease, Diabetes Mellitus Type 2
3 · Its place in the literature

Who cites it

1,394 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Development and Validation of NICVD-NQ Score for Predicting Short-Term Outcomes After Primary PCI.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Article

1,334 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

David C Goff
Donald M Lloyd-Jones
Glen Bennett
Sean Coady
Ralph B D'Agostino
Raymond Gibbons
Philip Greenland
Daniel T Lackland
Daniel Levy
Christopher J O'Donnell
Jennifer G Robinson
J Sanford Schwartz
Susan T Shero
Sidney C Smith
Paul Sorlie
Neil J Stone
Peter W F Wilson

Funding

Framingham Project/LevyZIAHL006001 · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · 2025 to 2025
$3.9M
Intramural NIH HHS Z99 HL999999
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

American Heart AssociationBlood PressureCardiologyCardiovascular DiseasesDietHumansMorbidityRisk AssessmentRisk FactorsSocieties, MedicalSodium, DietaryUnited StatesSodium, DietaryACC/AHA Practice Guidelinebiomarkerscardiovascular diseasecholesterolprimary preventionrisk assessmentrisk reduction behavior

Identifiers

PMID24239921
PMCPMC4700825

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.